EQS-News
Drägerwerk AG & Co. KGaA: Dräger’s annual shareholders’ meeting resolves on a significant dividend increase
- Significant dividend raised for fiscal year 2025
- Record net sales and strong EBIT improvement in 2025
- Positive outlook with expected sales and margin growth
|
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): AGM/EGM/Dividend Dräger’s annual shareholders’ meeting resolves on a significant dividend increase |
- Record net sales and significant earnings increase in fiscal year 2025
- Very good progress in improving profitability
- Third consecutive dividend increase
- Outlook remains positive
Lübeck – Drägerwerk AG & Co. KGaA held its annual shareholders’ meeting 2026 today. Among other things, the Executive Board reported on the business performance last year. The shareholders approved the proposal to significantly increase the dividend for 2025.
Successful fiscal year 2025
“In 2025, we remained on course for success – and generated the highest net sales in our Company’s history. Both divisions and all regions contributed to this growth,” said Stefan Dräger, Chairman
of the Executive Board of Drägerwerk Verwaltungs AG. “At around EUR 3.5 billion, net sales were slightly above our last forecast and approximately EUR 76 million above the level of the
exceptionally strong year of 2020 during the corona pandemic. This is a new record which, unlike during the pandemic, we have managed to achieve without any special economic conditions.”
In addition, Stefan Dräger addressed the progress made in improving profitability: “Our operational momentum helped our earnings before interest and taxes to continue to improve well; despite difficult underlying conditions, the EBIT rose by more than 20 percent to approximately EUR 233 million. The EBIT margin increased by almost one percentage point to 6.7 percent, therefore also exceeding our last forecast.”
Third consecutive dividend increase
The shareholders approved the joint proposal by the Supervisory Board and Executive Board to pay a year-on-year higher dividend of EUR 2.21 per common share (2024: EUR 1.97) and EUR 2.27 per
preferred share (2024: EUR 2.03) for fiscal year 2025.

